| intermediate filament based process | GO:0045103 | 27 | 0.811 | Mouse |
| intermediate filament cytoskeleton organization | GO:0045104 | 26 | 0.740 | Mouse |
| hair follicle morphogenesis | GO:0031069 | 29 | 0.729 | Mouse |
| regulation of keratinocyte differentiation | GO:0045616 | 11 | 0.617 | Mouse |
| apoptotic signaling pathway | GO:0097190 | 306 | 0.502 | |
| intermediate filament organization | GO:0045109 | 15 | 0.411 | Mouse |
| extrinsic apoptotic signaling pathway | GO:0097191 | 126 | 0.346 | |
| cytokine mediated signaling pathway | GO:0019221 | 115 | 0.345 | |
| cellular response to cytokine stimulus | GO:0071345 | 189 | 0.323 | |
| skin morphogenesis | GO:0043589 | 38 | 0.293 | Mouse |
| renal system development | GO:0072001 | 225 | 0.271 | |
| regulation of epidermal cell differentiation | GO:0045604 | 21 | 0.254 | Mouse |
| cellular amine metabolic process | GO:0044106 | 44 | 0.249 | |
| hair follicle development | GO:0001942 | 85 | 0.236 | Mouse |
| keratinocyte differentiation | GO:0030216 | 48 | 0.217 | Mouse |
| epidermis development | GO:0008544 | 187 | 0.215 | Mouse |
| negative regulation of epithelial cell proliferation | GO:0050680 | 64 | 0.205 | |
| inflammatory response | GO:0006954 | 244 | 0.191 | |
| regulation of body fluid levels | GO:0050878 | 162 | 0.186 | |
| regulation of response to wounding | GO:1903034 | 189 | 0.179 | |
| hair cycle | GO:0042633 | 90 | 0.173 | Mouse |
| cell substrate adhesion | GO:0031589 | 130 | 0.173 | |
| molting cycle | GO:0042303 | 90 | 0.170 | Mouse |
| t cell activation | GO:0042110 | 289 | 0.166 | |
| cell adhesion | GO:0007155 | 329 | 0.166 | |
| long chain fatty acid import | GO:0044539 | 2 | 0.161 | |
| negative regulation of proteolysis | GO:0045861 | 74 | 0.160 | |
| epithelium migration | GO:0090132 | 63 | 0.149 | |
| negative regulation of response to wounding | GO:1903035 | 77 | 0.132 | |
| regulation of cellular amino acid metabolic process | GO:0006521 | 5 | 0.128 | |
| cellular component assembly involved in morphogenesis | GO:0010927 | 139 | 0.128 | |
| protein maturation | GO:0051604 | 176 | 0.127 | |
| negative regulation of peptidase activity | GO:0010466 | 46 | 0.124 | |
| regulation of water loss via skin | GO:0033561 | 16 | 0.124 | |
| cell junction organization | GO:0034330 | 77 | 0.122 | |
| protein processing | GO:0016485 | 163 | 0.121 | |
| hepatocyte apoptotic process | GO:0097284 | 11 | 0.120 | |
| regulation of defense response | GO:0031347 | 233 | 0.118 | |
| regulation of peptidyl tyrosine phosphorylation | GO:0050730 | 93 | 0.117 | |
| regulation of peptidase activity | GO:0052547 | 96 | 0.117 | |
| thyroid stimulating hormone secreting cell differentiation | GO:0060129 | 4 | 0.116 | |
| regulation of protein maturation | GO:1903317 | 96 | 0.114 | |
| lung development | GO:0030324 | 164 | 0.112 | |
| extracellular structure organization | GO:0043062 | 148 | 0.111 | |
| circulatory system process | GO:0003013 | 197 | 0.109 | |
| embryonic placenta development | GO:0001892 | 98 | 0.108 | |
| regulation of cellular amine metabolic process | GO:0033238 | 20 | 0.108 | |
| kidney development | GO:0001822 | 213 | 0.107 | |
| regulation of epithelial cell proliferation | GO:0050678 | 141 | 0.103 | |
| cellular amino acid metabolic process | GO:0006520 | 103 | 0.102 | |
| negative regulation of protein maturation | GO:1903318 | 79 | 0.102 | |
| regulation of anagen | GO:0051884 | 1 | 0.099 | |
| wound healing | GO:0042060 | 157 | 0.098 | |
| negative regulation of cell proliferation | GO:0008285 | 296 | 0.097 | |
| striated muscle tissue development | GO:0014706 | 293 | 0.097 | |
| carboxylic acid biosynthetic process | GO:0046394 | 86 | 0.095 | |
| paraxial mesodermal cell fate commitment | GO:0048343 | 2 | 0.094 | |
| regulation of protein processing | GO:0070613 | 96 | 0.094 | |
| water homeostasis | GO:0030104 | 27 | 0.092 | |
| positive regulation of cellular amino acid metabolic process | GO:0045764 | 3 | 0.092 | |
| regulation of secretion by cell | GO:1903530 | 249 | 0.089 | Mouse |
| positive regulation of cellular amine metabolic process | GO:0033240 | 5 | 0.088 | |
| negative regulation of protein processing | GO:0010955 | 79 | 0.085 | |
| rhythmic process | GO:0048511 | 174 | 0.084 | |
| negative regulation of protein metabolic process | GO:0051248 | 282 | 0.084 | |
| urogenital system development | GO:0001655 | 261 | 0.083 | |
| small molecule biosynthetic process | GO:0044283 | 132 | 0.083 | |
| single organismal cell cell adhesion | GO:0016337 | 131 | 0.081 | |
| negative regulation of cell activation | GO:0050866 | 111 | 0.080 | |
| response to organic cyclic compound | GO:0014070 | 198 | 0.080 | |
| cell type specific apoptotic process | GO:0097285 | 268 | 0.079 | |
| heart contraction | GO:0060047 | 93 | 0.079 | |
| epidermis morphogenesis | GO:0048730 | 33 | 0.078 | Mouse |
| cellular ketone metabolic process | GO:0042180 | 84 | 0.078 | |
| epithelial cell development | GO:0002064 | 159 | 0.077 | Mouse |
| organic acid transport | GO:0015849 | 101 | 0.076 | |
| lipid biosynthetic process | GO:0008610 | 179 | 0.074 | |
| central nervous system vasculogenesis | GO:0022009 | 3 | 0.074 | |
| extracellular matrix organization | GO:0030198 | 147 | 0.074 | |
| actin filament organization | GO:0007015 | 113 | 0.072 | |
| oxidation reduction process | GO:0055114 | 342 | 0.071 | |
| stem cell differentiation | GO:0048863 | 268 | 0.069 | |
| respiratory tube development | GO:0030323 | 167 | 0.069 | |
| arachidonic acid metabolite production involved in inflammatory response | GO:0002538 | 2 | 0.069 | |
| skin development | GO:0043588 | 220 | 0.069 | Mouse |
| organic acid biosynthetic process | GO:0016053 | 86 | 0.069 | |
| regulation of endopeptidase activity | GO:0052548 | 89 | 0.067 | |
| amine metabolic process | GO:0009308 | 45 | 0.067 | |
| positive regulation of hair follicle development | GO:0051798 | 6 | 0.066 | |
| regulation of cell substrate adhesion | GO:0010810 | 73 | 0.066 | |
| negative regulation of endopeptidase activity | GO:0010951 | 44 | 0.066 | |
| multicellular organismal water homeostasis | GO:0050891 | 23 | 0.065 | |
| regulation of cytokine production | GO:0001817 | 266 | 0.065 | |
| septum primum development | GO:0003284 | 4 | 0.065 | |
| regulation of anatomical structure size | GO:0090066 | 178 | 0.064 | |
| negative regulation of molecular function | GO:0044092 | 258 | 0.064 | |
| cardiac muscle cell differentiation | GO:0055007 | 69 | 0.064 | |
| rhodopsin mediated signaling pathway | GO:0016056 | 4 | 0.061 | |
| spermatogenesis | GO:0007283 | 284 | 0.059 | Mouse |
| blood circulation | GO:0008015 | 195 | 0.059 | |
| isoprenoid metabolic process | GO:0006720 | 29 | 0.059 | |
| positive regulation of anagen | GO:0051885 | 1 | 0.059 | |
| posttranscriptional regulation of gene expression | GO:0010608 | 155 | 0.058 | |
| regulation of cellular ketone metabolic process | GO:0010565 | 66 | 0.058 | |
| negative regulation of immune system process | GO:0002683 | 209 | 0.058 | |
| negative regulation of cellular component organization | GO:0051129 | 194 | 0.058 | |
| tissue migration | GO:0090130 | 68 | 0.058 | |
| nitrogen compound transport | GO:0071705 | 271 | 0.058 | |
| stem cell development | GO:0048864 | 219 | 0.058 | |
| negative regulation of hydrolase activity | GO:0051346 | 71 | 0.058 | |
| gland development | GO:0048732 | 330 | 0.057 | |
| tissue regeneration | GO:0042246 | 22 | 0.057 | |
| regulation of phosphatidylcholine biosynthetic process | GO:2001245 | 2 | 0.056 | |
| striated muscle contraction | GO:0006941 | 45 | 0.055 | |
| fatty acid metabolic process | GO:0006631 | 121 | 0.055 | |
| intermediate filament bundle assembly | GO:0045110 | 3 | 0.055 | |
| organic anion transport | GO:0015711 | 137 | 0.054 | |
| epithelial cell proliferation | GO:0050673 | 174 | 0.054 | |
| androgen biosynthetic process | GO:0006702 | 4 | 0.054 | |
| cell communication by electrical coupling involved in cardiac conduction | GO:0086064 | 2 | 0.054 | |
| placenta development | GO:0001890 | 140 | 0.054 | |
| single organism cell adhesion | GO:0098602 | 156 | 0.054 | |
| digestion | GO:0007586 | 40 | 0.053 | |
| wnt signaling pathway | GO:0016055 | 188 | 0.052 | |
| cholesterol homeostasis | GO:0042632 | 44 | 0.052 | |
| terpenoid metabolic process | GO:0006721 | 25 | 0.051 | |
| regulation of extent of cell growth | GO:0061387 | 52 | 0.051 | |
| regulation of cell activation | GO:0050865 | 289 | 0.051 | |
| regulation of proteolysis | GO:0030162 | 164 | 0.050 | |
| cell junction assembly | GO:0034329 | 52 | 0.050 | |
| cell cell junction organization | GO:0045216 | 72 | 0.050 | |
| regulation of cell growth | GO:0001558 | 91 | 0.050 | |
| regulation of chemotaxis | GO:0050920 | 53 | 0.049 | |
| regulation of wnt signaling pathway | GO:0030111 | 123 | 0.048 | |
| positive regulation of canonical wnt signaling pathway involved in controlling type b pancreatic cell proliferation | GO:2000081 | 1 | 0.048 | |
| renal outer medulla development | GO:0072054 | 2 | 0.048 | |
| regulation of hormone levels | GO:0010817 | 211 | 0.048 | |
| muscle cell differentiation | GO:0042692 | 261 | 0.048 | |
| regulation of protein secretion | GO:0050708 | 82 | 0.047 | Mouse |
| t cell differentiation | GO:0030217 | 174 | 0.047 | |
| aromatic compound catabolic process | GO:0019439 | 286 | 0.046 | |
| negative regulation of fibroblast growth factor production | GO:0090272 | 2 | 0.046 | |
| regulation of phospholipid biosynthetic process | GO:0071071 | 3 | 0.046 | |
| positive regulation of secretion | GO:0051047 | 130 | 0.045 | |
| regulation of lymphocyte activation | GO:0051249 | 240 | 0.045 | |
| cellular response to growth factor stimulus | GO:0071363 | 197 | 0.045 | |
| blood vessel morphogenesis | GO:0048514 | 285 | 0.045 | |
| foramen ovale closure | GO:0035922 | 1 | 0.045 | |
| leukotriene production involved in inflammatory response | GO:0002540 | 2 | 0.044 | |
| cell growth | GO:0016049 | 130 | 0.044 | |
| regulation of canonical wnt signaling pathway involved in controlling type b pancreatic cell proliferation | GO:2000079 | 1 | 0.044 | |
| sphingolipid metabolic process | GO:0006665 | 45 | 0.044 | |
| response to vitamin a | GO:0033189 | 1 | 0.044 | |
| regulation of hydrolase activity | GO:0051336 | 246 | 0.044 | |
| positive regulation of transforming growth factor beta2 production | GO:0032915 | 2 | 0.043 | |
| regulation of renin secretion into blood stream | GO:1900133 | 4 | 0.043 | |
| positive regulation of growth | GO:0045927 | 104 | 0.043 | |
| epithelial tube morphogenesis | GO:0060562 | 303 | 0.043 | |
| negative regulation of lymphocyte activation | GO:0051250 | 91 | 0.043 | |
| positive regulation of cell projection organization | GO:0031346 | 95 | 0.042 | |
| negative regulation of inflammatory response | GO:0050728 | 61 | 0.042 | |
| fibroblast growth factor production | GO:0090269 | 4 | 0.042 | |
| renal system process | GO:0003014 | 48 | 0.042 | |
| digestive system development | GO:0055123 | 200 | 0.042 | |
| striated muscle cell development | GO:0055002 | 125 | 0.042 | |
| regulation of cell adhesion | GO:0030155 | 154 | 0.042 | |
| negative regulation of phosphorus metabolic process | GO:0010563 | 184 | 0.041 | |
| regulation of cysteine type endopeptidase activity involved in apoptotic process | GO:0043281 | 62 | 0.041 | |
| regulation of establishment of protein localization | GO:0070201 | 181 | 0.041 | Mouse |
| regulation of axon extension | GO:0030516 | 43 | 0.041 | |
| positive regulation of cell growth | GO:0030307 | 33 | 0.040 | |
| regulation of actin cytoskeleton organization | GO:0032956 | 84 | 0.040 | |
| negative regulation of cellular protein metabolic process | GO:0032269 | 247 | 0.040 | |
| cellular modified amino acid metabolic process | GO:0006575 | 63 | 0.040 | |
| canonical wnt signaling pathway involved in regulation of type b pancreatic cell proliferation | GO:0044343 | 1 | 0.039 | |
| ossification | GO:0001503 | 216 | 0.039 | |
| tumor necrosis factor mediated signaling pathway | GO:0033209 | 13 | 0.038 | |
| hormone metabolic process | GO:0042445 | 86 | 0.038 | |
| regulation of testosterone biosynthetic process | GO:2000224 | 2 | 0.038 | |
| tissue remodeling | GO:0048771 | 102 | 0.038 | |
| negative regulation of synapse assembly | GO:0051964 | 3 | 0.038 | |
| hematopoietic progenitor cell differentiation | GO:0002244 | 143 | 0.038 | |
| atrial ventricular junction remodeling | GO:0003294 | 2 | 0.037 | |
| membrane lipid metabolic process | GO:0006643 | 53 | 0.037 | |
| negative regulation of defense response | GO:0031348 | 77 | 0.037 | |
| positive regulation of rna polymerase ii transcriptional preinitiation complex assembly | GO:0045899 | 2 | 0.037 | |
| sa node cell action potential | GO:0086015 | 4 | 0.037 | |
| regulation of translation | GO:0006417 | 71 | 0.037 | |
| cell communication by chemical coupling | GO:0010643 | 2 | 0.037 | |
| protein citrullination | GO:0018101 | 2 | 0.037 | |
| muscle cell development | GO:0055001 | 133 | 0.037 | |
| ion transmembrane transport | GO:0034220 | 361 | 0.037 | |
| keratinization | GO:0031424 | 9 | 0.037 | |
| transmembrane receptor protein serine threonine kinase signaling pathway | GO:0007178 | 194 | 0.037 | |
| mesonephric tubule development | GO:0072164 | 94 | 0.037 | |
| av node cell to bundle of his cell communication | GO:0086067 | 2 | 0.036 | |
| sterol homeostasis | GO:0055092 | 45 | 0.036 | |
| lymphocyte differentiation | GO:0030098 | 242 | 0.036 | |
| establishment of skin barrier | GO:0061436 | 14 | 0.036 | |
| cellular homeostasis | GO:0019725 | 240 | 0.036 | |
| cellular nitrogen compound catabolic process | GO:0044270 | 280 | 0.036 | |
| oxygen homeostasis | GO:0032364 | 2 | 0.035 | |
| developmental maturation | GO:0021700 | 193 | 0.035 | Mouse |
| neuron projection extension | GO:1990138 | 64 | 0.035 | |
| regulation of apoptotic signaling pathway | GO:2001233 | 197 | 0.035 | |
| calcium ion homeostasis | GO:0055074 | 127 | 0.035 | |
| regulation of cysteine type endopeptidase activity | GO:2000116 | 65 | 0.035 | |
| regulation of cell cycle | GO:0051726 | 281 | 0.035 | |
| regulation of actin filament based process | GO:0032970 | 99 | 0.035 | |
| defense response to other organism | GO:0098542 | 197 | 0.034 | |
| response to inorganic substance | GO:0010035 | 96 | 0.034 | Mouse |
| cellular response to acid chemical | GO:0071229 | 68 | 0.034 | Rat |
| positive regulation of interleukin 8 secretion | GO:2000484 | 1 | 0.034 | |
| regulation of cell motility | GO:2000145 | 236 | 0.034 | |
| cell fate commitment | GO:0045165 | 210 | 0.034 | |
| stem cell maintenance | GO:0019827 | 130 | 0.034 | |
| muscle tissue development | GO:0060537 | 308 | 0.034 | |
| axis elongation involved in somitogenesis | GO:0090245 | 4 | 0.033 | |
| planar cell polarity pathway involved in cardiac right atrium morphogenesis | GO:0061349 | 2 | 0.033 | |
| cellular protein complex assembly | GO:0043623 | 116 | 0.033 | |
| paramesonephric duct development | GO:0061205 | 3 | 0.033 | |
| regulation of cell projection organization | GO:0031344 | 206 | 0.033 | |
| translation | GO:0006412 | 93 | 0.033 | |
| defense response to bacterium | GO:0042742 | 119 | 0.033 | |
| peptidyl amino acid modification | GO:0018193 | 336 | 0.033 | |
| regulation of epidermis development | GO:0045682 | 33 | 0.033 | Mouse |
| actomyosin structure organization | GO:0031032 | 56 | 0.033 | |
| morphogenesis of a branching epithelium | GO:0061138 | 193 | 0.032 | |
| positive regulation of wnt signaling pathway | GO:0030177 | 45 | 0.032 | |
| myofibril assembly | GO:0030239 | 34 | 0.032 | |
| regulation of organelle organization | GO:0033043 | 289 | 0.032 | |
| myotube differentiation | GO:0014902 | 105 | 0.032 | |
| establishment of organelle localization | GO:0051656 | 122 | 0.032 | |
| regulation of ventricular cardiac muscle cell membrane depolarization | GO:0060373 | 2 | 0.032 | |
| testosterone biosynthetic process | GO:0061370 | 2 | 0.032 | |
| planar cell polarity pathway involved in pericardium morphogenesis | GO:0061354 | 2 | 0.032 | |
| sa node cell to atrial cardiac muscle cell signalling | GO:0086018 | 4 | 0.032 | |
| muscle system process | GO:0003012 | 141 | 0.031 | |
| heart morphogenesis | GO:0003007 | 178 | 0.031 | |
| regulation of cellular component size | GO:0032535 | 121 | 0.031 | |
| lung epithelium development | GO:0060428 | 37 | 0.031 | |
| rho protein signal transduction | GO:0007266 | 32 | 0.031 | |
| spemann organizer formation at the anterior end of the primitive streak | GO:0060064 | 1 | 0.031 | |
| lung induction | GO:0060492 | 3 | 0.031 | |
| regulation of inflammatory response | GO:0050727 | 147 | 0.031 | |
| regulation of engulfment of apoptotic cell | GO:1901074 | 2 | 0.031 | |
| nucleoside phosphate catabolic process | GO:1901292 | 222 | 0.030 | |
| limb development | GO:0060173 | 166 | 0.030 | |
| endocytosis | GO:0006897 | 168 | 0.030 | |
| negative regulation of phosphorylation | GO:0042326 | 166 | 0.030 | |
| central nervous system morphogenesis | GO:0021551 | 2 | 0.030 | |
| macromolecule catabolic process | GO:0009057 | 281 | 0.030 | |
| skeletal system development | GO:0001501 | 356 | 0.030 | |
| planar cell polarity pathway involved in ventricular septum morphogenesis | GO:0061348 | 2 | 0.030 | |
| renal inner medulla development | GO:0072053 | 3 | 0.030 | |
| interleukin 8 secretion | GO:0072606 | 3 | 0.030 | |
| regulation of satellite cell activation involved in skeletal muscle regeneration | GO:0014717 | 3 | 0.030 | |
| microtubule cytoskeleton organization | GO:0000226 | 157 | 0.030 | |
| planar cell polarity pathway involved in outflow tract morphogenesis | GO:0061347 | 2 | 0.030 | |
| endothelial cell migration | GO:0043542 | 44 | 0.030 | |
| regulation of secretion | GO:0051046 | 274 | 0.029 | Mouse |
| fatty acid derivative metabolic process | GO:1901568 | 33 | 0.029 | |
| regulation of cell cell adhesion mediated by cadherin | GO:2000047 | 2 | 0.029 | |
| dna templated transcriptional preinitiation complex assembly | GO:0070897 | 4 | 0.029 | |
| cell maturation | GO:0048469 | 127 | 0.029 | Mouse |
| peptidyl tyrosine modification | GO:0018212 | 145 | 0.029 | |
| steroid metabolic process | GO:0008202 | 119 | 0.028 | |
| cellular lipid metabolic process | GO:0044255 | 323 | 0.028 | |
| regulation of neurotransmitter levels | GO:0001505 | 87 | 0.028 | |
| negative regulation of multi organism process | GO:0043901 | 68 | 0.028 | |
| cellular response to organic cyclic compound | GO:0071407 | 87 | 0.028 | |
| heterocycle catabolic process | GO:0046700 | 280 | 0.028 | |
| regulation of transforming growth factor beta2 production | GO:0032909 | 2 | 0.028 | |
| gas homeostasis | GO:0033483 | 3 | 0.028 | |
| negative regulation of canonical wnt signaling pathway | GO:0090090 | 51 | 0.028 | |
| anion transport | GO:0006820 | 177 | 0.028 | |
| actin mediated cell contraction | GO:0070252 | 15 | 0.028 | |
| regulation of membrane depolarization during action potential | GO:0098902 | 1 | 0.028 | |
| regulation of neuron projection development | GO:0010975 | 169 | 0.028 | |
| positive regulation of cell activation | GO:0050867 | 158 | 0.028 | |
| ubiquitin dependent smad protein catabolic process | GO:0030579 | 2 | 0.028 | |
| uterus morphogenesis | GO:0061038 | 2 | 0.028 | |
| regulation of protein transport | GO:0051223 | 163 | 0.028 | Mouse |
| positive regulation of branching involved in lung morphogenesis | GO:0061047 | 4 | 0.028 | |
| regulation of cytoskeleton organization | GO:0051493 | 122 | 0.027 | |
| embryonic placenta morphogenesis | GO:0060669 | 25 | 0.027 | |
| cardiac muscle tissue development | GO:0048738 | 130 | 0.027 | |
| regulation of kidney development | GO:0090183 | 40 | 0.027 | |
| developmental cell growth | GO:0048588 | 84 | 0.027 | |
| peptide transport | GO:0015833 | 133 | 0.027 | |
| paraxial mesodermal cell differentiation | GO:0048342 | 2 | 0.027 | |
| reactive oxygen species metabolic process | GO:0072593 | 84 | 0.027 | |
| actin filament based movement | GO:0030048 | 23 | 0.027 | |
| mesonephric duct morphogenesis | GO:0072180 | 4 | 0.027 | |
| retina homeostasis | GO:0001895 | 23 | 0.027 | |
| regulation of rho protein signal transduction | GO:0035023 | 71 | 0.027 | |
| non canonical wnt signaling pathway involved in heart development | GO:0061341 | 3 | 0.027 | |
| organic hydroxy compound metabolic process | GO:1901615 | 203 | 0.027 | |
| male gamete generation | GO:0048232 | 285 | 0.026 | Mouse |
| midbrain hindbrain boundary maturation | GO:0021732 | 1 | 0.026 | |
| ribose phosphate metabolic process | GO:0019693 | 291 | 0.026 | |
| positive regulation of stem cell proliferation | GO:2000648 | 59 | 0.026 | |
| sensory perception | GO:0007600 | 245 | 0.026 | |
| heart field specification | GO:0003128 | 6 | 0.026 | |
| regulation of transmembrane receptor protein serine threonine kinase signaling pathway | GO:0090092 | 112 | 0.026 | |
| ceramide metabolic process | GO:0006672 | 31 | 0.026 | |
| midgut development | GO:0007494 | 4 | 0.026 | |
| cell matrix adhesion | GO:0007160 | 68 | 0.026 | |
| syncytium formation by plasma membrane fusion | GO:0000768 | 42 | 0.026 | |
| positive regulation of protein modification process | GO:0031401 | 299 | 0.026 | |
| negative regulation of protein phosphorylation | GO:0001933 | 126 | 0.026 | |
| myoblast differentiation involved in skeletal muscle regeneration | GO:0014835 | 3 | 0.026 | |
| positive regulation of fat cell proliferation | GO:0070346 | 1 | 0.026 | |
| female genitalia morphogenesis | GO:0048807 | 3 | 0.026 | |
| morphogenesis of a branching structure | GO:0001763 | 203 | 0.026 | |
| vascular endothelial growth factor receptor signaling pathway | GO:0048010 | 24 | 0.025 | |
| response to molecule of bacterial origin | GO:0002237 | 143 | 0.025 | |
| response to growth factor | GO:0070848 | 198 | 0.025 | |
| ear development | GO:0043583 | 200 | 0.025 | |
| positive regulation of mesenchymal cell proliferation | GO:0002053 | 33 | 0.025 | |
| regulation of lymphocyte differentiation | GO:0045619 | 107 | 0.025 | |
| positive regulation of hair cycle | GO:0042635 | 7 | 0.025 | |
| organophosphate catabolic process | GO:0046434 | 232 | 0.025 | |
| regulation of cellular response to growth factor stimulus | GO:0090287 | 82 | 0.025 | |
| erk1 and erk2 cascade | GO:0070371 | 77 | 0.025 | |
| non canonical wnt signaling pathway via mapk cascade | GO:0038030 | 3 | 0.025 | |
| oviduct development | GO:0060066 | 3 | 0.025 | |
| neurotransmitter transport | GO:0006836 | 76 | 0.025 | |
| organelle localization | GO:0051640 | 179 | 0.025 | |
| regulation of feeding behavior | GO:0060259 | 3 | 0.025 | |
| mesonephric epithelium development | GO:0072163 | 94 | 0.025 | |
| metanephros development | GO:0001656 | 79 | 0.025 | |
| lung morphogenesis | GO:0060425 | 50 | 0.024 | |
| negative regulation of phosphate metabolic process | GO:0045936 | 184 | 0.024 | |
| cellular amino acid biosynthetic process | GO:0008652 | 22 | 0.024 | |
| protein catabolic process | GO:0030163 | 221 | 0.024 | |
| cell cell junction assembly | GO:0007043 | 27 | 0.024 | |
| renal vesicle induction | GO:0072034 | 3 | 0.024 | |
| negative regulation of wnt signaling pathway | GO:0030178 | 73 | 0.024 | |
| purine containing compound catabolic process | GO:0072523 | 213 | 0.024 | |
| regulation of ion transmembrane transport | GO:0034765 | 119 | 0.024 | |
| organic cyclic compound catabolic process | GO:1901361 | 295 | 0.024 | |
| positive regulation of epidermis development | GO:0045684 | 13 | 0.024 | |
| positive regulation of cell morphogenesis involved in differentiation | GO:0010770 | 72 | 0.024 | |
| outer medullary collecting duct development | GO:0072060 | 1 | 0.024 | |
| organ induction | GO:0001759 | 21 | 0.024 | |
| purine nucleotide catabolic process | GO:0006195 | 211 | 0.024 | |
| monocarboxylic acid biosynthetic process | GO:0072330 | 61 | 0.023 | |
| t cell apoptotic process | GO:0070231 | 39 | 0.023 | |
| regulation of multi organism process | GO:0043900 | 111 | 0.023 | |
| regulation of erk1 and erk2 cascade | GO:0070372 | 71 | 0.023 | |
| positive regulation of cell substrate adhesion | GO:0010811 | 47 | 0.023 | |
| ventricular cardiac muscle cell action potential | GO:0086005 | 4 | 0.023 | |
| respiratory system development | GO:0060541 | 190 | 0.023 | |
| positive regulation of interleukin 8 production | GO:0032757 | 2 | 0.023 | |
| cardiac septum development | GO:0003279 | 59 | 0.023 | |
| oligopeptide transmembrane transport | GO:0035672 | 4 | 0.023 | |
| amide transport | GO:0042886 | 138 | 0.023 | |
| axis elongation | GO:0003401 | 30 | 0.023 | |
| lipoxygenase pathway | GO:0019372 | 5 | 0.023 | |
| positive regulation of cell motility | GO:2000147 | 116 | 0.023 | |
| tertiary branching involved in mammary gland duct morphogenesis | GO:0060748 | 3 | 0.023 | |
| regulation of wound healing | GO:0061041 | 40 | 0.023 | |
| morphogenesis of embryonic epithelium | GO:0016331 | 159 | 0.023 | |
| milk ejection | GO:0060156 | 1 | 0.023 | |
| carboxylic acid transport | GO:0046942 | 100 | 0.023 | |
| skeletal muscle satellite cell maintenance involved in skeletal muscle regeneration | GO:0014834 | 3 | 0.023 | |
| cytokine production | GO:0001816 | 319 | 0.023 | |
| angiogenesis | GO:0001525 | 201 | 0.023 | |
| endodermal cell fate specification | GO:0001714 | 4 | 0.023 | |
| transmembrane transport | GO:0055085 | 412 | 0.023 | |
| nucleobase containing small molecule metabolic process | GO:0055086 | 352 | 0.023 | |
| inorganic ion transmembrane transport | GO:0098660 | 234 | 0.023 | |
| negative regulation of intracellular signal transduction | GO:1902532 | 167 | 0.022 | |
| transforming growth factor beta receptor signaling pathway | GO:0007179 | 71 | 0.022 | |
| positive regulation of high voltage gated calcium channel activity | GO:1901843 | 1 | 0.022 | |
| atrial cardiac muscle cell differentiation | GO:0055011 | 2 | 0.022 | |
| foregut regionalization | GO:0060423 | 3 | 0.022 | |
| regulation of blood pressure | GO:0008217 | 93 | 0.022 | |
| neurotransmitter secretion | GO:0007269 | 62 | 0.022 | |
| purine containing compound metabolic process | GO:0072521 | 311 | 0.022 | |
| negative regulation of cell migration | GO:0030336 | 59 | 0.022 | |
| regulation of t cell activation | GO:0050863 | 170 | 0.022 | |
| kidney epithelium development | GO:0072073 | 121 | 0.022 | |
| negative regulation of growth | GO:0045926 | 99 | 0.022 | |
| retinoid metabolic process | GO:0001523 | 24 | 0.022 | |
| sarcomere organization | GO:0045214 | 24 | 0.022 | |
| cerebellum formation | GO:0021588 | 1 | 0.021 | |
| regulation of systemic arterial blood pressure mediated by a chemical signal | GO:0003044 | 33 | 0.021 | |
| inflammatory response to wounding | GO:0090594 | 4 | 0.021 | |
| positive regulation of neuron differentiation | GO:0045666 | 141 | 0.021 | |
| regulation of reproductive process | GO:2000241 | 66 | 0.021 | |
| regulation of cytoplasmic transport | GO:1903649 | 112 | 0.021 | |
| protein localization to plasma membrane | GO:0072659 | 57 | 0.021 | |
| spemann organizer formation | GO:0060061 | 2 | 0.021 | |
| regulation of smoothened signaling pathway | GO:0008589 | 58 | 0.021 | |
| organ growth | GO:0035265 | 117 | 0.021 | |
| mesonephros development | GO:0001823 | 97 | 0.021 | |
| planar cell polarity pathway involved in heart morphogenesis | GO:0061346 | 3 | 0.021 | |
| fertilization | GO:0009566 | 127 | 0.021 | |
| lung field specification | GO:0060424 | 3 | 0.021 | |
| glycerophospholipid biosynthetic process | GO:0046474 | 32 | 0.021 | |
| maintenance of location | GO:0051235 | 89 | 0.021 | |
| chondrocyte hypertrophy | GO:0003415 | 4 | 0.021 | |
| negative regulation of androgen biosynthetic process | GO:2000180 | 1 | 0.021 | |
| membrane organization | GO:0061024 | 245 | 0.021 | |
| positive regulation of voltage gated calcium channel activity | GO:1901387 | 2 | 0.021 | |
| ribonucleoside triphosphate metabolic process | GO:0009199 | 220 | 0.021 | |
| l glutamate uptake involved in synaptic transmission | GO:0051935 | 3 | 0.021 | |
| cell cell adhesion via plasma membrane adhesion molecules | GO:0098742 | 40 | 0.021 | |
| regulation of fibroblast growth factor production | GO:0090270 | 4 | 0.021 | |
| lateral sprouting involved in mammary gland duct morphogenesis | GO:0060599 | 2 | 0.021 | |
| cellular response to parathyroid hormone stimulus | GO:0071374 | 2 | 0.021 | |
| glycosyl compound catabolic process | GO:1901658 | 206 | 0.021 | |
| blood coagulation | GO:0007596 | 76 | 0.021 | |
| somatotropin secreting cell differentiation | GO:0060126 | 4 | 0.020 | |
| negative regulation of protein modification process | GO:0031400 | 163 | 0.020 | |
| epithelial tube branching involved in lung morphogenesis | GO:0060441 | 28 | 0.020 | |
| interleukin 5 secretion | GO:0072603 | 2 | 0.020 | |
| cellular response to tumor necrosis factor | GO:0071356 | 21 | 0.020 | |
| cation transmembrane transport | GO:0098655 | 266 | 0.020 | |
| lipid homeostasis | GO:0055088 | 63 | 0.020 | |
| substrate dependent cell migration cell extension | GO:0006930 | 4 | 0.020 | |
| developmental induction | GO:0031128 | 34 | 0.020 | |
| positive regulation of neuron projection development | GO:0010976 | 79 | 0.020 | |
| detection of external stimulus | GO:0009581 | 61 | 0.020 | |
| cellular response to transforming growth factor beta stimulus | GO:0071560 | 88 | 0.020 | |
| positive regulation of cell cycle | GO:0045787 | 92 | 0.020 | |
| hypophysis morphogenesis | GO:0048850 | 3 | 0.020 | |
| regulation of heart contraction | GO:0008016 | 77 | 0.020 | |
| cell cell signaling involved in lung development | GO:0060495 | 1 | 0.020 | |
| establishment of planar polarity involved in nephron morphogenesis | GO:0072046 | 1 | 0.020 | |
| synaptic vesicle localization | GO:0097479 | 59 | 0.020 | |
| nucleoside triphosphate metabolic process | GO:0009141 | 230 | 0.020 | |
| hindbrain formation | GO:0021576 | 1 | 0.020 | |
| regulation of voltage gated calcium channel activity | GO:1901385 | 4 | 0.020 | |
| ventricular cardiac myofibril assembly | GO:0055005 | 3 | 0.020 | |
| steroid biosynthetic process | GO:0006694 | 47 | 0.020 | |
| monocarboxylic acid metabolic process | GO:0032787 | 191 | 0.020 | |
| carbohydrate homeostasis | GO:0033500 | 128 | 0.019 | |
| rna polymerase ii transcriptional preinitiation complex assembly | GO:0051123 | 3 | 0.019 | |
| microtubule based process | GO:0007017 | 236 | 0.019 | |
| positive regulation of cell migration | GO:0030335 | 109 | 0.019 | |
| positive regulation of mapk cascade | GO:0043410 | 170 | 0.019 | |
| satellite cell activation involved in skeletal muscle regeneration | GO:0014901 | 3 | 0.019 | |
| regulation of system process | GO:0044057 | 200 | 0.019 | |
| corticotropin hormone secreting cell differentiation | GO:0060128 | 3 | 0.019 | |
| purine nucleotide metabolic process | GO:0006163 | 302 | 0.019 | |
| regulation of ketone biosynthetic process | GO:0010566 | 2 | 0.019 | |
| myoblast differentiation | GO:0045445 | 52 | 0.019 | |
| glycerophospholipid metabolic process | GO:0006650 | 71 | 0.019 | |
| positive regulation of interleukin 6 production | GO:0032755 | 37 | 0.019 | |
| diterpenoid metabolic process | GO:0016101 | 24 | 0.019 | |
| glycosyl compound metabolic process | GO:1901657 | 246 | 0.019 | |
| symbiosis encompassing mutualism through parasitism | GO:0044403 | 83 | 0.019 | |
| response to acid chemical | GO:0001101 | 111 | 0.019 | Rat |
| sensory perception of smell | GO:0007608 | 26 | 0.019 | |
| biomineral tissue development | GO:0031214 | 64 | 0.019 | |
| negative regulation of interleukin 13 production | GO:0032696 | 2 | 0.019 | |
| protein localization to membrane | GO:0072657 | 108 | 0.019 | |
| mesonephric tubule morphogenesis | GO:0072171 | 63 | 0.018 | |
| lens development in camera type eye | GO:0002088 | 62 | 0.018 | Mouse |
| carbohydrate derivative catabolic process | GO:1901136 | 231 | 0.018 | |
| ureteric bud development | GO:0001657 | 94 | 0.018 | |
| positive regulation of cytokine production | GO:0001819 | 174 | 0.018 | |
| i kappab kinase nf kappab signaling | GO:0007249 | 85 | 0.018 | |
| fatty acid derivative biosynthetic process | GO:1901570 | 15 | 0.018 | |
| insulin secretion | GO:0030073 | 89 | 0.018 | |
| regulation of mesonephros development | GO:0061217 | 24 | 0.018 | |
| regulation of sequence specific dna binding transcription factor activity | GO:0051090 | 106 | 0.018 | |
| cytokine metabolic process | GO:0042107 | 71 | 0.018 | |
| negative regulation of testosterone biosynthetic process | GO:2000225 | 1 | 0.018 | |
| regulation of metal ion transport | GO:0010959 | 106 | 0.018 | |
| connective tissue development | GO:0061448 | 179 | 0.018 | |
| regulation of membrane depolarization during cardiac muscle cell action potential | GO:1900825 | 1 | 0.018 | |
| negative regulation of apoptotic signaling pathway | GO:2001234 | 104 | 0.018 | |
| glycerolipid biosynthetic process | GO:0045017 | 50 | 0.018 | |
| response to tumor necrosis factor | GO:0034612 | 26 | 0.018 | |
| branching morphogenesis of an epithelial tube | GO:0048754 | 159 | 0.018 | |
| regulation of t cell apoptotic process | GO:0070232 | 28 | 0.018 | |
| cell communication by electrical coupling | GO:0010644 | 4 | 0.018 | |
| regulation of extrinsic apoptotic signaling pathway | GO:2001236 | 77 | 0.018 | |
| cellular response to starvation | GO:0009267 | 57 | 0.018 | |
| sulfur compound metabolic process | GO:0006790 | 100 | 0.017 | |
| regulation of heart rate | GO:0002027 | 36 | 0.017 | |
| gtp catabolic process | GO:0006184 | 143 | 0.017 | |
| establishment of vesicle localization | GO:0051650 | 81 | 0.017 | |
| unsaturated fatty acid biosynthetic process | GO:0006636 | 15 | 0.017 | |
| ribonucleoside triphosphate catabolic process | GO:0009203 | 199 | 0.017 | |
